ABL Bio Market Cap

ABL Bio has a market cap or net worth of 3.54 trillion as of July 17, 2025. Its market cap has increased by 235.13% in one year.

Market Cap

3.54T

Enterprise Value

3.48T

Revenue

27.63B

Ranking

n/a

PE Ratio

n/a

Stock Price

73,300.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 3.54T, an increase of 482.07%. That is a compound annual growth rate of 30.69%.

Market Cap History

Date	Market Cap	% Change
Jul 17, 2025	3,542.54B	145.39%
Dec 30, 2024	1,443.63B	22.53%
Dec 28, 2023	1,178.16B	7.19%
Dec 29, 2022	1,099.13B	5.54%
Dec 30, 2021	1,041.42B	-27.59%
Dec 30, 2020	1,438.26B	31.46%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	73.38T
Celltrion	39.09T
ALTEOGEN	23.78T
Yuhan	8,332.69B
SK Biopharmaceuticals	7,486.75B
HLB Co., Ltd.	6,834.05B
PharmaResearch	5,880.54B
Peptron	5,474.88B

Market Cap Rankings